Ferromagnetic Screening Workflows & Detection Systems

Ferromagnetic Screening Workflows & Detection Systems

The Two-Tier Screening Architecture

Relying on a single screening checkpoint or a self-administered paper form is inherently unsafe. Patients may misunderstand terminology or omit remote procedures. To mitigate this risk, the ACR mandates a two-tier screening methodology.

[Tier 1: Zone II Written Form] ───> [Tier 2: Zone II Verbal Interview] ───> [100% Gowning & Locker Protocol] ───> [FMDS Screening & Level 2 Sign-Off]
(Completed by Patient/Surrogate)    (Line-by-Line Clinical Review)           (Metal-Free Attire & Lockers)           (Ferromagnetic Detection & Entry)

Tier 1: The Written Screening Questionnaire (Zone II)

The first tier consists of a standardized, exhaustive paper or electronic screening questionnaire administered in Zone II before the patient crosses the threshold into Zone III. The questionnaire must be completed by the patient or their legally authorized surrogate.

• Detailed Anatomical and Device Inventory: The questionnaire must include specific, non-technical prompts covering all major organ systems and device categories:
  • Cardiac Devices: Pacemakers, implantable cardioverter-defibrillators (ICDs), pacemaker leads, epicardial wires, prosthetic heart valves, annuloplasty rings, and cardiac loop recorders.
  • Neurological Implants: Intracranial aneurysm clips, deep brain stimulators (DBS), programmable ventriculoperitoneal (VP) shunts, neurostimulators, and cochlear implants.
  • Ocular Foreign Bodies: History of foreign body injury to the eye from grinding, welding, machining, or sheet metal work (requiring orbital radiographic clearance prior to scan entry).
  • Vascular and Abdominal Devices: Vena cava filters, vascular access ports (chemoports), embolization coils, endovascular stents, and surgical hemostatic clips.
  • Orthopedic Implants: Artificial joint replacements, bone screws, plates, intramedullary rods, and spinal fusion cages.
  • Cutaneous and Cosmetic Items: Transdermal medication delivery patches, tattoos, permanent eyeliner, microblading, body piercings, and cosmetic magnetic eyelashes.
• Language and literacy: Use the facility's qualified language service, accessible forms and teach-back. A signature without comprehension is not adequate screening. Do not routinely substitute relatives for qualified interpretation; applicable rules contain limited exceptions.

Tier 2: In-Depth Verbal Interview & Physical Verification

The second tier is an interactive, line-by-line verbal interview conducted privately in Zone II by Level 2 personnel (or a trained Imaging Assistant under direct Level 2 supervision). The interviewer reviews every single questionnaire item directly with the patient, translating medical jargon into plain conversational language.

• Probing Conversational Questions: Rather than asking generic questions, staff must use targeted inquiries:
  • "Have you ever had an operation or procedure of any kind, even as an infant or child?"
  • "Have you ever had an accident where a tiny piece of metal flew into your eye or skin? Did an eye doctor have to remove metal from your eye?"
  • "Do you have any devices implanted beneath your skin, such as a heart monitor, nerve stimulator, or insulin pump?"
  • "Are you wearing any medicated patches on your skin for pain, smoking cessation, or blood pressure?"
• Physical Inspection and Verification:
  • Surgical Scar Assessment: Visual inspection of exposed skin (such as the chest, neck, abdomen, or extremities) can reveal surgical scars that contradict a negative written history (e.g., a midline sternotomy scar indicating past open-heart surgery, or a left subclavicular scar indicating a cardiac pacemaker pocket).
  • Transdermal Medication Patches: Many transdermal patches (e.g., nitroglycerin, clonidine, nicotine, fentanyl, scopolamine) contain microscopic aluminum or metallic backing to regulate drug diffusion. During RF pulsing, the metallic layer acts as a conductor, generating rapid inductive heating that produces severe second- and third-degree skin burns. Patches containing metal must be removed prior to the scan (after consulting the ordering clinician) and replaced with a fresh patch immediately following the procedure.
  • Cosmetic and Body Modifications: Tattoos, microblading, and permanent makeup containing iron oxide pigments can experience localized radiofrequency heating and cutaneous burning. Patients must be warned to report any tingling or warmth immediately. Cosmetic magnetic eyelashes, which use microscopic ferromagnetic magnets to adhere to eyelids, must be completely removed to prevent violent ocular dislodgement in Zone IV.
  • Subcutaneous Palpation: With the patient's informed permission, safety staff palpate reported subcutaneous lumps, port reservoirs, or cardiac loop recorders to verify anatomical location.

The 100% Gowning and Locker Protocol

Allowing patients to undergo MR examinations wearing personal street clothing represents a severe clinical hazard. Standard civilian clothing frequently conceals hidden ferromagnetic threats:

• Metal zippers, snaps, rivets, eyelets, safety pins, and wire stays in undergarments (such as underwire bras).
• Items forgotten in pockets: pocketknives, carbon steel keys, ink pens, lighters, coins, paperclips, bobby pins, transit cards, and cell phones.
• The Athleisure and Antimicrobial Fabric Hazard: Modern athletic apparel, yoga pants, moisture-wicking shirts, and antimicrobial fabrics frequently incorporate microscopic metallic threads (silver, copper, or zinc micro-particles) woven into the textile matrix to inhibit bacterial odor. These metallic fibers are invisible to the naked eye. When exposed to high-power radiofrequency fields, these conductive fibers form resonant antenna loops, causing severe full-thickness burns during scanning.

Mandatory Gowning Policy

Follow the facility's gowning policy and current ACR recommendations for removal of potentially conductive clothing and items before the MR procedure. Facility-provided verified attire reduces hidden-metal risks; do not claim that every setting has an identical gowning checkpoint before Zone III. All personal belongings, wallets, credit cards, phones, and jewelry are secured inside dedicated lockers located within Zone II.

Mandatory Screening of Companions, Visitors, and Non-MR Personnel

A critical exam rule is the Universal Screening Mandate: any individual entering Zone III or Zone IV is exposed to the static magnetic field, regardless of their role or reason for entry.

• Companions and Family Members: Parents accompanying a pediatric patient, spouses assisting an elderly or anxious individual, and adult children comforting an impaired parent must undergo the exact same rigorous two-tier screening process as the patient. They must complete the written questionnaire, complete the verbal interview, remove all jewelry, watches, and external metal, empty their pockets, and change into scrubs or undergo complete ferromagnetic detection. If an accompanying mother has an unvetted cardiac pacemaker, she is strictly barred from entering Zone IV, regardless of the child's emotional distress.
• Clinical Visitors and External Staff: Inpatient floor nurses, transport aides, respiratory therapists, surgical scrub techs, and security guards entering Zone III/IV to assist with patient positioning, life support, or combative patient restraint must be screened before entry. No professional status, uniform, or hospital badge exempts an individual from complete ferromagnetic clearance.

Medical Conditions and Pregnancy Screening

Ask about pregnancy possibility, claustrophobia, inability to lie flat, prior difficulties, pain and the need for sedation. Screen children and accompanying adults with age-appropriate support. Check actual weight, coil fit, bore clearance and manufacturer-required insulating separation for larger patients. Do not diagnose safety from appearance or assume a wider bore automatically provides enough space for the patient and coil.

Pregnancy is not an automatic ban on clinically indicated noncontrast MRI, including in the first trimester. The responsible clinical team weighs the indication and protocol, and the technologist follows the approved exposure plan. Gadolinium is a separate decision and is not routinely administered in pregnancy; it requires the appropriate documented clinical assessment. The assistant gathers and communicates the history rather than approving exposure or promising zero fetal risk. Local policy also addresses pregnant staff and companions; patient imaging and occupational access are different questions.